Contact Lens Spectrum


September 2014

Document #226

(p. 13) GP Insights – Optimizing GP Performance in Dry Eye Patients
By Edward S. Bennett, OD, MSEd, FAAO; Stephanie Woo, OD, & Robert M. Grohe, OD, FAAO

    1. Bennett ES. Gas-permeable material selection. In Bennett ES, Henry VA. Clinical Manual of Contact Lenses (4th ed.). Lippincott Williams & Wilkins, Philadelphia. 2014:89-111.

    2. Henry VA, Bennett ES, Forrest JF. Clinical investigation of the Paraperm EW rigid gas-permeable contact lens. Am J Optom Physiol Opt. 1987;64:313-320.

    3. DeNaeyer, G. Modern scleral contact lens fitting. Contact Lens Spectrum. 2010 June;25:20-25.

    4. Ward, M. GP contact lens care pearls. Contact Lens Spectrum. 2012 Oct;27:23.

    5. Accessed 5/16/2014.

(p. 15) Contact Lens Design & Materials – A More Breathable Way to Bring Color to Patients’ Eyes
By David L. Kading, OD, FAAO

    1. Nichols J. Contact Lenses 2013. Contact Lens Spectrum. 2013 Jan;29:22-28.

(p. 21) Contact Lens Care & Compliance – Contact Lens Discomfort and Contact Lens Care
By Susan J. Gromacki, OD, MS, FAAO

    1. Nichols JJ, Willcox MDP, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary. Investigative Ophthalmology and Vision Science. 2013;54:TFOS7-TFOS13.

    2. Jones L, Brennan NA, González-Méijome J, et al. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Materials, Design, and Care Subcommittee. Investigative Ophthalmology and Vision Science. 2013;54:TFOS37-TFOS70.

(p. 18) What Contact Lens Dropout Costs and How to Prevent It
By John Rumpakis, OD, MBA, & Mile Brujic, OD, FAAO




    4) Truong TN, Graham AD, Lin MC. Factors in contact lens symptoms: evidence from a multistudy database. Optom Vis Sci 2014 Feb;91(2):133-141.

    5) Efron N, Jones L, Bron AJ, Knop E, Arita R, Barabino S, McDermott AM, Villani E, Willcox MD, Markoulli M; members of the TFOS International Workshop on Contact Lens Discomfort. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee. Invest Ophthalmol Vis Sci 2013 Oct;18;54(11): TFOS98-TFOS122.

    6) Weissman BA, Mondino BJ. Risk factors for contact lens associated microbial keratitis. Cont Lens Anterior Eye 2002 Mar;25(1):3-9.

    7) Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011 Mar;52(4):1938-78.

    8) Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Nonobvious obstructive meibomian gland dysfunction. Cornea 2010 Dec;29(12):1333-1345.

    9) Lee SY, Petznick A, Tong L. Associations of systemic diseases, smoking and contact lens wear with severity of dry eye. Ophthalmic Physiol Opt 2012 Nov;32(6):518-526.

    10) Shen L, Suresh L, Lindemann M, Xuan J, Malyavantham K, Ambrus JL Jr. Novel autoantibodies in Sjogren's syndrome. Clin Immunol 2012 Dec;145(3):251-255.

    11) Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: A review. Cont Lens Anterior Eye 2010 Apr;33(2):49-54.

    12) Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf 2010 Jan;8(1):18-28.

    13) Pinazo-Durán MD, Galbis-Estrada C, Pons-Vázquez S, Cantú-Dibildox J, Marco-Ramírez C, Benítez-del-Castillo J. Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interv Aging 2013;8:139-148.

    14) Brignole-Baudouin F, Baudouin C, Aragona P, Rolando M, Labetoulle M, Pisella PJ, Barabino S, Siou-Mermet R, Creuzot-Garcher C. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 2011 Nov;89(7):591-597.

    15) Kangari H, Eftekhari MH, Sardari S, Hashemi H, Salamzadeh J, Ghassemi-Broumand M, Khabazkhoob M. Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology 2013 Nov;120(11):2191-2196.

    16) Kawakita T, Kawabata F, Tsuji T, Kawashima M, Shimmura S, Tsubota K. Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomed Res 2013;34(5):215-220.

    17) Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997 Aug;74(8):624–631.

    18) Uchino M, Schaumberg DA, Dogru M, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 2008 Nov;115(11):1982–1988.

    19) Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology 2011 Dec;118(12):2361–2367.

    20) Dumbleton K, Woods C, Jones L, Richter D, Fonn D. Comfort and vision with silicone hydrogel lenses: effect of compliance. Optom Vis Sci 2010 Jun;87(6):421–425.

    21) Dumbleton KA, Spafford MM, Sivak A, Jones LW. Exploring compliance: a mixed-methods study of contact lens wearer perspectives. Optom Vis Sci 2013 Aug;90(8):898-908.

    22) Ramamoorthy P, Nichols JJ. Compliance factors associated with contact lens-related dry eye. Eye Contact Lens 2014 Jan;40(1):17-22.

    23) Thekveli S, Qiu Y, Kapoor Y, Kumi A, Liang W, Pruitt J. Structure-property relationship of delefilcon A lenses. BCLA 2012.

    24) Rudy A, Huo Y, Perry SS, Ketelson HA. Surface mechanical and tribological properties of Silicone Hydrogels measured by atomic force microscopy. ARVO 2012.

    25) Koffler BH, Sears JJ. Myopia control in children through refractive therapy gas permeable contact lenses: is it for real? Am J Ophthalmol 2013 Dec;156(6):1076-1081.


    27) Swarbrick HA. Orthokeratology review and update. Clin Exp Optom 2006 May;89(3):124-143.

    28) Hiraoka T, Okamoto C, Ishii Y, Kakita T, Okamoto F, Takahashi H, Oshika T. Patient satisfaction and clinical outcomes after overnight orthokeratology. Optom Vis Sci 2009 Jul;86(7):875-882.

(p. 28) Troubleshooting Hybrid Lenses
By Jeffrey Sonsino, OD, FAAO

    1. Pilskalns B, Fink BA, Hill RM. Oxygen demands with hybrid contact lenses. Optom Vis Sci. 2007 Apr;84:334-342.

    2. Papas E. Corneal vascularisation and contact lenses. Arch Soc Esp Oftalmol. 2006 Jun;81:309-12.

    3. Brennan, NA, Bruce, AS. Imobile Lens Syndrome. In: Brennan, NA, Bruce, AS. A Guide to Clinical Lens Management. CIBA Vision Management, Zurich, Switerland. 1993:37.

    4. Swarbrick, HA, Holden, BA. Complications of Hydrogel Extended Wear Lenses. In: Silbert, JA. Anterior Segment Complications of Contact Lens Wear. Churchill Livingstone, New York. 1994:289-316.

    5. Dumbleton K, Jones L. Extended and Continuous Wear. in Clinical Manual of Contact Lenses. E. Bennett and V. Henry, Eds. Williams and Wilkins. 2008:410-443.

    6. Edrington TB, Barr JT, Zadnik K, et al. Standardized rigid contact lens fitting protocol for keratoconus. Optom Vis Sci. 1996;73:369-375.

(p. 36) Impact of Unilateral Price Policies
By S. Barry Eiden, OD, FAAO, & Jordan Kassalow, OD

    1. Leegin Creative Leather Products, Inc. v. PSKS, Inc., 551 U.S. 877 (2007).

    2. Nichols J. Contact Lenses 2012. Contact Lens Spectrum. 2013 Jan;28:24-29.

    3. Tikoo S, Mather B. The changed legality of resale price maintenance and price implications. Business Horizons. 2011;54:415-423.

    4. Tesler LG. Why Should Manufacturers Want Fair Trade. Journal of Law and Economics. 1960;3:86-105.

    5. Gift P. Price Fixing and Minimum Resale Price Restrictions Are Two Different Animals. Graziadio Business Review. 2009; 12(2).

    6. Fogel J, Zidile C. Contact lenses purchased over the internet places individuals potentially at risk for harmful eye care practices. Optometry. 2008 Jan;79:23-35.

    7. Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology. 2008 Oct;115:1655-1662.

    8. Bausch + Lomb ULTRA contact lens Unilateral Price Policy, February 26, 2014.

    9. Letter from Laura Angelini, President, Johnson & Johnson Vision Care, Inc. – North America. June 24, 2014.

(p. 43) Contact Lens Practice Pearls – Tune up Your Contact Lens Department
By Jason R. Miller, OD, MBA, FAAO

    1. Ritson, M. Which Patients Are More Profitable? Contact Lens Spectrum. 2006 March;21:38-40, 42.

    2. Miller, J. Fitting Success of a New Color Silicone Hydrogel Contact Lens in Lotrafilcon B Clear Sphere Wearers. Poster presented at Optometry’s Meeting, June 2014.

(p. 46) The Scleral Lens Vault – Estimating Central Corneal Clearance
By Gregory W. DeNaeyer, OD, FAAO

    1. Yeung D, Sorbara L. Scleral Lens Clearance Assessment by Biomicroscopy. Poster presented at Global Specialty Lens Symposium 2014, Las Vegas.

    2. Dinardo A, Lotoczky J, Rosen C, et al. Introducing a Scleral Lens Fit Assessment Guide Based on Tear Layer Thickness. Poster presented at Global Specialty Lens Symposium 2014, Las Vegas.

    3. Chan N, Fuller D, Smith B. The Utility of Scleral Lens Center Thickness as a Biometric Ruler. Poster presented at Global Specialty Lens Symposium 2014, Las Vegas.

(p. 47) Treatment Plan – Managing Corneal Graft
By William L. Miller, OD, MS, PhD, FAAO

    1. Qazi Y, Hamrah P. Gene therapy in corneal transplantation. Semin Ophthalmol. 2013 Sep-Nov;28:287-300.

    2. Maumenee AE. Clinical aspects of the corneal homograft reaction. Invest Ophthalmol. 1962;1:244-252.

    3. Krachmer JH, Alldredge OC. Subepithelial infiltrates: a probable sign of corneal transplant rejection. Arch. Ophthalmol. 1978;96:2234-2237.

    4. Khodadoust AA, Silverstein AM. Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol. 1969;8:180-195.

    5. Panda A, Vanathi M, Kumar A, Dash Y, Priya S. Corneal graft rejection. Surv Ophthalmol. 2007 Jul-Aug;52:375-396.

    6. Joseph A, Raj D, Shanmuganathan V, Powell RJ, Dua HS. Tacrolimus immunosuppression in high-risk corneal grafts. Br J Ophthalmol. 2007; 91:51-55.

    7. Birnbaum F, Reis A, Böhringer D, et al. An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty. Transplantation. 2006;81:767-772.

    8. Reinhard T, Mayweg S, Sokolovska Y, et al. Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study. Transpl Int. 2005;18:703-708.

    9. Birnbaum F, Mayweg S, Reis A, et al. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. Eye (Lond). 2009;23:2063-2070.